|
Through her wigs a grandmother's life will go on
JoAnne Guerino died suddenly in January at the age of 80, and according to her grandchildren, Cassie Roden, 22, Michael Roden, 18, and Emma Kunjusankaran, 11, she suffered off and on for years with alopecia.
www2.independenttribune.com
Spring-Ford Reporter/The Valley ItemDatebook
DateBook Notes
www.montgomerynews.com
Study suggests physicians to individualize blood sugar targets for diabetic hemodialysis patients
Aggressive blood sugar control does not improve survival in diabetic patients with kidney failure, according to a study appearing in an upcoming issue of the Clinical Journal of the American Society Nephrology (CJASN). The results suggest that physicians should individualize blood sugar targets for these patients and not rely on recommendations based on studies in the general population.
www.news-medical.net
Maven Semantic: the Largest Database of International Autoimmune Research Professionals
DUBLIN----Maven Semantic announces updates to their Autoimmune Disease research database.
biz.yahoo.com
Abraxis BioScience And Specialised Therapeutics Announce Approval To Market ABRAXANE For Metastatic Breast Cancer In ...
Abraxis BioScience, Inc. (NASDAQ:ABII), a fully integrated, global biotechnology company, and Specialised Therapeutics Ltd. today announced that MEDSAFE, the New Zealand Medicines and Medical Devices Safety Authority, has approved for marketing ABRAXANE® (nanoparticle albumin-bound paclitaxel) for the treatment of metastatic breast cancer after failure of anthracycline therapy. Abraxis ...
mnt.to
Pageant winners honored
Two teenage pageant winners being honored at a recent Oakland County Board of Commissioners meeting received a proclamation from the county that theyll always remember.
theoaklandpress.com
Aphios awarded US patent for compositions, methods for treating diseases involving 5- reductase enzyme
Aphios® Corporation today announced that it was awarded United States Patent No. 7,744,935 B2 for "Compositions and Methods for Inhibiting 5- Reductase," granted June 29, 2010. This invention is related to compositions and methods for treating diseases involving the 5-alpha () reductase enzyme.
www.news-medical.net
The Leukemia & Lymphoma Society® and Shape Pharmaceuticals Partner to Advance Clinical Development of Novel, Topical ...
WHITE PLAINS, N.Y. and CAMBRIDGE, Mass., July 27 /PRNewswire/ -- The Leukemia & Lymphoma Society (LLS) and Shape Pharmaceuticals announced today that they have entered into a partnership to advance Shape's novel, topical treatment for cutaneous T-Cell lymphoma (CTCL) into clinical development. The compound, SHP-141, is a first-in-class topical histone deacetylase inhibitor with the potential ...
www.redorbit.com
Merck Grants License to LabCorp for Development of Test To Potentially Identify Patients Likely to Respond to ...
WHITEHOUSE STATION, N.J.----Merck today announced a non-exclusive license agreement with Laboratory Corporation of America® Holdings for the commercialization of a genetic test that may help predict the response of patients with Hepatitis C virus infection to peginterferon alpha-based therapy.
biz.yahoo.com
Aphios Awarded United States Patent for Compositions and Methods for Inhibiting 5-Alpha Reductase
WOBURN, Mass.----Aphios® Corporation today announced that it was awarded United States Patent No. 7,744,935 B2 for Compositions and Methods for Inhibiting 5- Reductase, granted June 29, 2010.
biz.yahoo.com
|
